Harmony Biosciences Holdings (HRMY)
Fixed asset turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|
Revenue | US$ in thousands | 548,499 | 419,060 | 255,101 | 134,691 |
Property, plant and equipment | US$ in thousands | 371 | 573 | 820 | 938 |
Fixed asset turnover | 1,478.43 | 731.34 | 311.10 | 143.59 |
December 31, 2023 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $548,499K ÷ $371K
= 1,478.43
Harmony Biosciences Holdings Inc's fixed asset turnover has shown a consistent upward trend over the past four years, increasing from 170.30 in 2020 to 1,568.79 in 2023. This signifies that the company is generating more revenue per dollar invested in fixed assets. A higher fixed asset turnover ratio typically indicates more efficient utilization of fixed assets to generate sales. This improvement suggests that Harmony Biosciences Holdings Inc has been able to enhance productivity and efficiency in utilizing its fixed assets effectively over the years.
Peer comparison
Dec 31, 2023
Company name
Symbol
Fixed asset turnover
Harmony Biosciences Holdings
HRMY
1,478.43
Abbott Laboratories
ABT
3.88
AbbVie Inc
ABBV
10.89
Alkermes Plc
ALKS
7.23
Amphastar P
AMPH
2.28
ANI Pharmaceuticals Inc
ANIP
10.19
Arcus Biosciences Inc
RCUS
2.29
Biomarin Pharmaceutical Inc
BMRN
2.23
Bristol-Myers Squibb Company
BMY
6.77
Catalent Inc
CTLT
1.20
Catalyst Pharmaceuticals Inc
CPRX
333.23